These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 7878032)

  • 21. Role of trypsin-like cleavage at arginine 192 in the enzymatic and cytotonic activities of Escherichia coli heat-labile enterotoxin.
    Grant CC; Messer RJ; Cieplak W
    Infect Immun; 1994 Oct; 62(10):4270-8. PubMed ID: 7927684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A genetically detoxified derivative of heat-labile Escherichia coli enterotoxin induces neutralizing antibodies against the A subunit.
    Pizza M; Fontana MR; Giuliani MM; Domenighini M; Magagnoli C; Giannelli V; Nucci D; Hol W; Manetti R; Rappuoli R
    J Exp Med; 1994 Dec; 180(6):2147-53. PubMed ID: 7964489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Immunopotency of the recombinant urease B subunit vaccine of Helicobacter pylori after intranasal administration to mice].
    Gao ZG; Zou QM; Guo G; Guo TS; Zou QM; Zeng WK; Xie QH
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Jan; 19(1):68-70. PubMed ID: 15132912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetically detoxified mutants of heat-labile enterotoxin from Escherichia coli are effective adjuvants for induction of cytotoxic T-cell responses against HIV-1 gag-p55.
    Neidleman JA; Vajdy M; Ugozzoli M; Ott G; O'Hagan D
    Immunology; 2000 Sep; 101(1):154-60. PubMed ID: 11012767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mucosal immunogenicity and adjuvant activity of the recombinant A subunit of the Escherichia coli heat-labile enterotoxin.
    De Haan L; Holtrop M; Verweij WR; Agsteribbe E; Wilschut J
    Immunology; 1999 Aug; 97(4):706-13. PubMed ID: 10457227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intranasal immunization with SAG1 and nontoxic mutant heat-labile enterotoxins protects mice against Toxoplasma gondii.
    Bonenfant C; Dimier-Poisson I; Velge-Roussel F; Buzoni-Gatel D; Del Giudice G; Rappuoli R; Bout D
    Infect Immun; 2001 Mar; 69(3):1605-12. PubMed ID: 11179334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mucosal adjuvant properties of mutant LT-IIa and LT-IIb enterotoxins that exhibit altered ganglioside-binding activities.
    Nawar HF; Arce S; Russell MW; Connell TD
    Infect Immun; 2005 Mar; 73(3):1330-42. PubMed ID: 15731030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TLR2-dependent modulation of dendritic cells by LT-IIa-B5, a novel mucosal adjuvant derived from a type II heat-labile enterotoxin.
    Lee CH; Masso-Welch P; Hajishengallis G; Connell TD
    J Leukoc Biol; 2011 Nov; 90(5):911-21. PubMed ID: 21791597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutants of Escherichia coli heat-labile enterotoxin as an adjuvant for nasal influenza vaccine.
    Komase K; Tamura S; Matsuo K; Watanabe K; Hattori N; Odaka A; Suzuki Y; Kurata T; Aizawa C
    Vaccine; 1998; 16(2-3):248-54. PubMed ID: 9607038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Attenuated Escherichia coli strains expressing the colonization factor antigen I (CFA/I) and a detoxified heat-labile enterotoxin (LThK63) enhance clearance of ETEC from the lungs of mice and protect mice from intestinal ETEC colonization and LT-induced fluid accumulation.
    Byrd W; Boedeker EC
    Vet Immunol Immunopathol; 2013 Mar; 152(1-2):57-67. PubMed ID: 23122616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of site-directed mutagenesis of Escherichia coli heat-labile enterotoxin on ADP-ribosyltransferase activity and interaction with ADP-ribosylation factors.
    Stevens LA; Moss J; Vaughan M; Pizza M; Rappuoli R
    Infect Immun; 1999 Jan; 67(1):259-65. PubMed ID: 9864224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mucosal immunogenicity of the Escherichia coli heat-labile enterotoxin: role of the A subunit.
    de Haan L; Holtrop M; Verweij WR; Agsteribbe E; Wilschut J
    Vaccine; 1996 Mar; 14(4):260-6. PubMed ID: 8744549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heat-labile enterotoxin of Escherichia coli and its site-directed mutant LTK63 enhance the proliferative and cytotoxic T-cell responses to intranasally co-immunized synthetic peptides.
    Partidos CD; Salani BF; Pizza M; Rappuoli R
    Immunol Lett; 1999 Apr; 67(3):209-16. PubMed ID: 10369128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the reactogenicity, adjuvanticity and antigenicity of LT(R192G) and LT(R192G/L211A) by intradermal immunization in mice.
    Maciel M; Smith M; Poole ST; Laird RM; Rollenhagen JE; Kaminski RW; Wenzel H; Bourgeois AL; Savarino SJ
    PLoS One; 2019; 14(11):e0224073. PubMed ID: 31682624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The adjuvant effect of Vibrio cholerae and Escherichia coli heat-labile enterotoxins is linked to their ADP-ribosyltransferase activity.
    Lycke N; Tsuji T; Holmgren J
    Eur J Immunol; 1992 Sep; 22(9):2277-81. PubMed ID: 1381311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of cAMP in mucosal adjuvanticity of Escherichia coli heat-labile enterotoxin (LT).
    Cheng E; Cárdenas-Freytag L; Clements JD
    Vaccine; 1999 Aug; 18(1-2):38-49. PubMed ID: 10501233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens.
    Clements JD; Hartzog NM; Lyon FL
    Vaccine; 1988 Jun; 6(3):269-77. PubMed ID: 3048010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MHC class I-restricted cytotoxic lymphocyte responses induced by enterotoxin-based mucosal adjuvants.
    Simmons CP; Mastroeni P; Fowler R; Ghaem-maghami M; Lycke N; Pizza M; Rappuoli R; Dougan G
    J Immunol; 1999 Dec; 163(12):6502-10. PubMed ID: 10586042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mucosal and systemic antibody responses after peroral or intranasal immunization: effects of conjugation to enterotoxin B subunits and/or of co-administration with free toxin as adjuvant.
    Rask C; Fredriksson M; Lindblad M; Czerkinsky C; Holmgren J
    APMIS; 2000 Mar; 108(3):178-86. PubMed ID: 10752686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between a low toxicity of the mutant A subunit of enterotoxigenic Escherichia coli enterotoxin and its strong adjuvant action.
    Tsuji T; Yokochi T; Kamiya H; Kawamoto Y; Miyama A; Asano Y
    Immunology; 1997 Feb; 90(2):176-82. PubMed ID: 9135544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.